Apixaban Teva 5 mg (60 Film-Coated Tablets) is a direct oral anticoagulant (selective Factor Xa inhibitor) produced by Teva Pharmaceutical Industries Ltd. By selectively inhibiting Factor Xa, Apixaban prevents thrombin generation and clot formation, significantly reducing the risk of stroke, systemic embolism, deep vein thrombosis (DVT), and pulmonary embolism (PE).

Indications: Apixaban Teva 5 mg is indicated for:

• Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF)

• Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)

• Prevention of recurrent DVT and PE in adult patients

Reasons for Use:

• Diagnosed non-valvular atrial fibrillation requiring protection against thromboembolic risk

• Active DVT or PE requiring therapeutic anticoagulation

• Preference for a reliable anticoagulant that does not require routine INR blood testing

• Physician recommendation for Factor Xa inhibitor therapy

Key Features:

• Active ingredient — Apixaban 5 mg

• Direct and selective Factor Xa inhibitor

• Standard 5 mg dosage for stroke prevention and DVT/PE treatment

• Film-coated tablets for ease of swallowing

• Pack containing 60 film-coated tablets

Dosage Form: Apixaban Teva 5 mg — Film-coated tablets (pack of 60 tablets)

Manufacturer: Teva Pharmaceutical Industries Ltd. (Teva)

Active Ingredients:

• Apixaban — 5 mg

#Apixaban #ApixabanTeva #Apixaban5mg #Teva #Anticoagulant #BloodThinner #StrokePrevention #ThrombosisPrevention #IsraeliPharmacy #MedsFromIsrael